Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$17.7K Sell
13,605
-4,895
-26% -$5.13K ﹤0.01% 2400
2023
Q4
$10.6K Hold
18,500
﹤0.01% 1779
2023
Q3
$13.9K Sell
18,500
-6,700
-27% -$5.1K ﹤0.01% 1688
2023
Q2
$18.4K Sell
25,200
-11,200
-31% -$10.4K ﹤0.01% 1636
2023
Q1
$27.5K Sell
36,400
-6,650
-15% -$6.18K ﹤0.01% 1613
2022
Q4
$41.4K Sell
43,050
-13,000
-23% -$18.4K ﹤0.01% 1551
2022
Q3
$122K Sell
56,050
-41,675
-43% -$144K ﹤0.01% 1195
2022
Q2
$342K Sell
97,725
-7,800
-7% -$29.1K 0.01% 995
2022
Q1
$532K Buy
+105,525
New +$535K 0.01% 853

Other funds holding VXRT

Cetera Advisors's VXRT Position: Q1 2024 in Review

Cetera Advisors reduced its Vaxart (VXRT) stake by 26% in Q1 2024, selling an estimated $5.13K and leaving 13,605 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Cetera Advisors first reported a position in VXRT in Q1 2022 and has held it in 9 quarters since. The position peaked at $532K in Q1 2022. 106 funds tracked by Wall St. Rank hold VXRT as of Q1 2024.

  • Cetera Advisors held 13,605 shares of Vaxart worth $17.7K as of Q1 2024.
  • Cetera Advisors sold 4,895 Vaxart shares in Q1 2024, an estimated $5.13K.
  • Vaxart made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2400 holding.
  • Cetera Advisors first reported a position in Vaxart in Q1 2022 and has held it in 9 quarters since.
  • Cetera Advisors's Vaxart position peaked at $532K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held Vaxart as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.